Primary hepatic angiosarcoma: A report of two cases and literature review

Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2015-05, Vol.21 (19), p.6088-6096
Hauptverfasser: Zhu, Yi-Ping, Chen, Yan-Min, Matro, Erik, Chen, Ren-Biao, Jiang, Zhi-Nong, Mou, Yi-Ping, Hu, Hong-Jie, Huang, Chao-Jie, Wang, Guan-Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6096
container_issue 19
container_start_page 6088
container_title World journal of gastroenterology : WJG
container_volume 21
creator Zhu, Yi-Ping
Chen, Yan-Min
Matro, Erik
Chen, Ren-Biao
Jiang, Zhi-Nong
Mou, Yi-Ping
Hu, Hong-Jie
Huang, Chao-Jie
Wang, Guan-Yu
description Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and outcomes of the two patients were collected and analyzed. Both patients underwent hepatectomy and had a postoperative survival time of 8 and 16 mo, respectively. A search of PubMed yielded eight references reporting 35 cases of PHA published between 2004 and 2013. On the basis of the presented cases and review of the literature, we endorse complete surgical resection as the mainstay definitive treatment of PHA, with adjuvant postoperative chemotherapy potentially improving survival. Palliative chemotherapy is an option in advanced hepatic angiosarcoma.
doi_str_mv 10.3748/wjg.v21.i19.6088
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4438048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1684429255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-d616dd46c421fab60a234a4f5ad7ed1ba363f6fb79117b6190c33c98a9892c383</originalsourceid><addsrcrecordid>eNpVkTtPwzAUhS0EoqWwM6GMLAl-xbEZkFDFo1IlGGC2bhyndZXUxU5b8e9J1VLBdId7zrmPD6FrgjNWcHm3XcyyDSWZIyoTWMoTNKSUqJRKjk_RkGBcpIrRYoAuYlxgTBnL6TkaUIGJ4oUcosl7cC2E72RuV9A5k8By5nyEYHwL98ljEuzKhy7xddJtfWIg2thrqqRxnQ3QrYPtJRtnt5forIYm2qtDHaHP56eP8Ws6fXuZjB-nqeGCdmkliKgqLgynpIZSYKCMA69zqApbkRKYYLWoy0IRUpSCKGwYM0qCkooaJtkIPexzV-uytZWxyy5Ao1f7O7QHp_93lm6uZ36jOWcS813A7SEg-K-1jZ1uXTS2aWBp_TpqIiTnVNE876V4LzXBxxhsfRxDsN4R0D0B3RPQPQG9I9Bbbv6udzT8vpz9AK9fhGI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1684429255</pqid></control><display><type>article</type><title>Primary hepatic angiosarcoma: A report of two cases and literature review</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zhu, Yi-Ping ; Chen, Yan-Min ; Matro, Erik ; Chen, Ren-Biao ; Jiang, Zhi-Nong ; Mou, Yi-Ping ; Hu, Hong-Jie ; Huang, Chao-Jie ; Wang, Guan-Yu</creator><creatorcontrib>Zhu, Yi-Ping ; Chen, Yan-Min ; Matro, Erik ; Chen, Ren-Biao ; Jiang, Zhi-Nong ; Mou, Yi-Ping ; Hu, Hong-Jie ; Huang, Chao-Jie ; Wang, Guan-Yu</creatorcontrib><description>Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and outcomes of the two patients were collected and analyzed. Both patients underwent hepatectomy and had a postoperative survival time of 8 and 16 mo, respectively. A search of PubMed yielded eight references reporting 35 cases of PHA published between 2004 and 2013. On the basis of the presented cases and review of the literature, we endorse complete surgical resection as the mainstay definitive treatment of PHA, with adjuvant postoperative chemotherapy potentially improving survival. Palliative chemotherapy is an option in advanced hepatic angiosarcoma.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v21.i19.6088</identifier><identifier>PMID: 26019478</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Biomarkers, Tumor - analysis ; Biopsy ; Case Report ; Chemoembolization, Therapeutic ; Chemotherapy, Adjuvant ; Fatal Outcome ; Female ; Hemangiosarcoma - chemistry ; Hemangiosarcoma - pathology ; Hemangiosarcoma - surgery ; Hepatectomy ; Humans ; Immunohistochemistry ; Liver Neoplasms - chemistry ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>World journal of gastroenterology : WJG, 2015-05, Vol.21 (19), p.6088-6096</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-d616dd46c421fab60a234a4f5ad7ed1ba363f6fb79117b6190c33c98a9892c383</citedby><cites>FETCH-LOGICAL-c462t-d616dd46c421fab60a234a4f5ad7ed1ba363f6fb79117b6190c33c98a9892c383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438048/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438048/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26019478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Yi-Ping</creatorcontrib><creatorcontrib>Chen, Yan-Min</creatorcontrib><creatorcontrib>Matro, Erik</creatorcontrib><creatorcontrib>Chen, Ren-Biao</creatorcontrib><creatorcontrib>Jiang, Zhi-Nong</creatorcontrib><creatorcontrib>Mou, Yi-Ping</creatorcontrib><creatorcontrib>Hu, Hong-Jie</creatorcontrib><creatorcontrib>Huang, Chao-Jie</creatorcontrib><creatorcontrib>Wang, Guan-Yu</creatorcontrib><title>Primary hepatic angiosarcoma: A report of two cases and literature review</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and outcomes of the two patients were collected and analyzed. Both patients underwent hepatectomy and had a postoperative survival time of 8 and 16 mo, respectively. A search of PubMed yielded eight references reporting 35 cases of PHA published between 2004 and 2013. On the basis of the presented cases and review of the literature, we endorse complete surgical resection as the mainstay definitive treatment of PHA, with adjuvant postoperative chemotherapy potentially improving survival. Palliative chemotherapy is an option in advanced hepatic angiosarcoma.</description><subject>Biomarkers, Tumor - analysis</subject><subject>Biopsy</subject><subject>Case Report</subject><subject>Chemoembolization, Therapeutic</subject><subject>Chemotherapy, Adjuvant</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Hemangiosarcoma - chemistry</subject><subject>Hemangiosarcoma - pathology</subject><subject>Hemangiosarcoma - surgery</subject><subject>Hepatectomy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Liver Neoplasms - chemistry</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkTtPwzAUhS0EoqWwM6GMLAl-xbEZkFDFo1IlGGC2bhyndZXUxU5b8e9J1VLBdId7zrmPD6FrgjNWcHm3XcyyDSWZIyoTWMoTNKSUqJRKjk_RkGBcpIrRYoAuYlxgTBnL6TkaUIGJ4oUcosl7cC2E72RuV9A5k8By5nyEYHwL98ljEuzKhy7xddJtfWIg2thrqqRxnQ3QrYPtJRtnt5forIYm2qtDHaHP56eP8Ws6fXuZjB-nqeGCdmkliKgqLgynpIZSYKCMA69zqApbkRKYYLWoy0IRUpSCKGwYM0qCkooaJtkIPexzV-uytZWxyy5Ao1f7O7QHp_93lm6uZ36jOWcS813A7SEg-K-1jZ1uXTS2aWBp_TpqIiTnVNE876V4LzXBxxhsfRxDsN4R0D0B3RPQPQG9I9Bbbv6udzT8vpz9AK9fhGI</recordid><startdate>20150521</startdate><enddate>20150521</enddate><creator>Zhu, Yi-Ping</creator><creator>Chen, Yan-Min</creator><creator>Matro, Erik</creator><creator>Chen, Ren-Biao</creator><creator>Jiang, Zhi-Nong</creator><creator>Mou, Yi-Ping</creator><creator>Hu, Hong-Jie</creator><creator>Huang, Chao-Jie</creator><creator>Wang, Guan-Yu</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150521</creationdate><title>Primary hepatic angiosarcoma: A report of two cases and literature review</title><author>Zhu, Yi-Ping ; Chen, Yan-Min ; Matro, Erik ; Chen, Ren-Biao ; Jiang, Zhi-Nong ; Mou, Yi-Ping ; Hu, Hong-Jie ; Huang, Chao-Jie ; Wang, Guan-Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-d616dd46c421fab60a234a4f5ad7ed1ba363f6fb79117b6190c33c98a9892c383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomarkers, Tumor - analysis</topic><topic>Biopsy</topic><topic>Case Report</topic><topic>Chemoembolization, Therapeutic</topic><topic>Chemotherapy, Adjuvant</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Hemangiosarcoma - chemistry</topic><topic>Hemangiosarcoma - pathology</topic><topic>Hemangiosarcoma - surgery</topic><topic>Hepatectomy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Liver Neoplasms - chemistry</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Yi-Ping</creatorcontrib><creatorcontrib>Chen, Yan-Min</creatorcontrib><creatorcontrib>Matro, Erik</creatorcontrib><creatorcontrib>Chen, Ren-Biao</creatorcontrib><creatorcontrib>Jiang, Zhi-Nong</creatorcontrib><creatorcontrib>Mou, Yi-Ping</creatorcontrib><creatorcontrib>Hu, Hong-Jie</creatorcontrib><creatorcontrib>Huang, Chao-Jie</creatorcontrib><creatorcontrib>Wang, Guan-Yu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Yi-Ping</au><au>Chen, Yan-Min</au><au>Matro, Erik</au><au>Chen, Ren-Biao</au><au>Jiang, Zhi-Nong</au><au>Mou, Yi-Ping</au><au>Hu, Hong-Jie</au><au>Huang, Chao-Jie</au><au>Wang, Guan-Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary hepatic angiosarcoma: A report of two cases and literature review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2015-05-21</date><risdate>2015</risdate><volume>21</volume><issue>19</issue><spage>6088</spage><epage>6096</epage><pages>6088-6096</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and outcomes of the two patients were collected and analyzed. Both patients underwent hepatectomy and had a postoperative survival time of 8 and 16 mo, respectively. A search of PubMed yielded eight references reporting 35 cases of PHA published between 2004 and 2013. On the basis of the presented cases and review of the literature, we endorse complete surgical resection as the mainstay definitive treatment of PHA, with adjuvant postoperative chemotherapy potentially improving survival. Palliative chemotherapy is an option in advanced hepatic angiosarcoma.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>26019478</pmid><doi>10.3748/wjg.v21.i19.6088</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2015-05, Vol.21 (19), p.6088-6096
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4438048
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Biomarkers, Tumor - analysis
Biopsy
Case Report
Chemoembolization, Therapeutic
Chemotherapy, Adjuvant
Fatal Outcome
Female
Hemangiosarcoma - chemistry
Hemangiosarcoma - pathology
Hemangiosarcoma - surgery
Hepatectomy
Humans
Immunohistochemistry
Liver Neoplasms - chemistry
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Magnetic Resonance Imaging
Male
Middle Aged
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
title Primary hepatic angiosarcoma: A report of two cases and literature review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T00%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20hepatic%20angiosarcoma:%20A%20report%20of%20two%20cases%20and%20literature%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Zhu,%20Yi-Ping&rft.date=2015-05-21&rft.volume=21&rft.issue=19&rft.spage=6088&rft.epage=6096&rft.pages=6088-6096&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v21.i19.6088&rft_dat=%3Cproquest_pubme%3E1684429255%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1684429255&rft_id=info:pmid/26019478&rfr_iscdi=true